Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system

Fanny Lemarié; Daniel R. Croft; Rothwelle J. Tate; Kevin M. Ryan; Christine Dufès

doi:10.1016/j.biomaterials.2011.12.019

Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system

Fanny Lemarié, Daniel R. Croft, Rothwelle J. Tate, Kevin M. Ryan, Christine Dufès

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2701-2709
Number of pages	9
Journal	Biomaterials
Volume	33
Issue number	9
DOIs	https://doi.org/10.1016/j.biomaterials.2011.12.019
Publication status	Published - Mar 2012
Externally published	Yes

ASJC Scopus Subject Areas

Bioengineering
Ceramics and Composites
Biophysics
Biomaterials
Mechanics of Materials

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.biomaterials.2011.12.019

Cite this

Lemarié, F., Croft, D. R., Tate, R. J., Ryan, K. M., & Dufès, C. (2012). Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system. Biomaterials, 33(9), 2701-2709. https://doi.org/10.1016/j.biomaterials.2011.12.019

@article{8e4e0509427c4e9bbd9f766eff80c85e,

title = "Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system",

author = "Fanny Lemari{\'e} and Croft, {Daniel R.} and Tate, {Rothwelle J.} and Ryan, {Kevin M.} and Christine Duf{\`e}s",

note = "Funding Information: This work was supported by a research grant from Medical Research Scotland . The IVIS was funded with an equipment grant ( No. ME0442 ) from The Wellcome Trust. Work in the Tumor Cell Death Laboratory (KMR) is supported by Cancer Research UK and The Association for International Cancer Research .",

year = "2012",

month = mar,

doi = "10.1016/j.biomaterials.2011.12.019",

language = "English",

volume = "33",

pages = "2701--2709",

journal = "Biomaterials",

issn = "0142-9612",

publisher = "Elsevier Limited",

number = "9",

}

TY - JOUR

T1 - Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system

AU - Lemarié, Fanny

AU - Croft, Daniel R.

AU - Tate, Rothwelle J.

AU - Ryan, Kevin M.

AU - Dufès, Christine

N1 - Funding Information: This work was supported by a research grant from Medical Research Scotland . The IVIS was funded with an equipment grant ( No. ME0442 ) from The Wellcome Trust. Work in the Tumor Cell Death Laboratory (KMR) is supported by Cancer Research UK and The Association for International Cancer Research .

PY - 2012/3

Y1 - 2012/3

UR - http://www.scopus.com/inward/record.url?scp=84855966213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855966213&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2011.12.019

DO - 10.1016/j.biomaterials.2011.12.019

M3 - Article

C2 - 22200536

AN - SCOPUS:84855966213

SN - 0142-9612

VL - 33

SP - 2701

EP - 2709

JO - Biomaterials

JF - Biomaterials

IS - 9

ER -

Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this